Oguma T - Search Results

1

A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium.

Eckhardt SG, Burris HA, Eckardt JR, Weiss G, Rodriguez G, Rothenberg M, Rinaldi D, Barrington R, Kuhn JG, Masuo K, Sudo K, Atsumi R, Oguma T, Higashi L, Fields S, Smetzer L, Von Hoff DD. Eckhardt SG, et al. Among authors: oguma t. Ann Oncol. 1996 Jul;7(5):491-6. doi: 10.1093/oxfordjournals.annonc.a010638. Ann Oncol. 1996. PMID: 8839904 Free article. Clinical Trial.

2

Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer.

Schöffski P, Thate B, Beutel G, Bolte O, Otto D, Hofmann M, Ganser A, Jenner A, Cheverton P, Wanders J, Oguma T, Atsumi R, Satomi M. Schöffski P, et al. Among authors: oguma t. Ann Oncol. 2004 Apr;15(4):671-9. doi: 10.1093/annonc/mdh141. Ann Oncol. 2004. PMID: 15033678 Free article. Clinical Trial.

3

Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks.

Minami H, Fujii H, Igarashi T, Itoh K, Tamanoi K, Oguma T, Sasaki Y. Minami H, et al. Among authors: oguma t. Clin Cancer Res. 2001 Oct;7(10):3056-64. Clin Cancer Res. 2001. PMID: 11595695 Clinical Trial.

4

Pharmacokinetics of platinum in cancer patients following intravenous infusion of cis-diammine(glycolato)platinum, 254-S.

Ota K, Oguma T, Shimamura K. Ota K, et al. Among authors: oguma t. Anticancer Res. 1994 May-Jun;14(3B):1383-7. Anticancer Res. 1994. PMID: 8067710

5

Relationship between plasma concentration of morphine and analgesic effectiveness.

Yokokawa N, Hiraga K, Oguma T, Konishi M. Yokokawa N, et al. Among authors: oguma t. Postgrad Med J. 1991;67 Suppl 2:S50-4. Postgrad Med J. 1991. PMID: 1758816

6

[Pharmacokinetics of cis-diammine (glycolato) platinum (254-S), a new platinum antitumor agent, following an intravenous and intraperitoneal infusion bioactive platinum concentration profile].

Hirabayashi K, Okada E, Oguma T, Shimamura K. Hirabayashi K, et al. Among authors: oguma t. Gan To Kagaku Ryoho. 1990 Nov;17(11):2221-7. Gan To Kagaku Ryoho. 1990. PMID: 2241186 Japanese.

7

Pharmacokinetics of flomoxef in mucosal tissue of the middle ear and mastoid following intravenous administration in humans.

Saito H, Kimura T, Takeda T, Kishimoto S, Oguma T, Shimamura K. Saito H, et al. Among authors: oguma t. Chemotherapy. 1990;36(3):193-9. doi: 10.1159/000238766. Chemotherapy. 1990. PMID: 2338030

8

Evaluation of Bayesian predictability of vancomycin concentration in patients with various degrees of renal function.

Ohnishi A, Yano Y, Shimamura K, Oguma T. Ohnishi A, et al. Among authors: oguma t. Biol Pharm Bull. 2001 Dec;24(12):1446-50. doi: 10.1248/bpb.24.1446. Biol Pharm Bull. 2001. PMID: 11767122 Free article.

9

[The prophylactic effects of latamoxef against the postoperative infections to open heart surgery. Studies on the penetration of latamoxef into the pericardial fluid and the auricle of heart].

Matsuura Y, Tamura M, Yamashina H, Higo M, Fujii T, Yamamoto M, Shimamoto H, Yamada H, Oguma T, Shimamura K. Matsuura Y, et al. Among authors: oguma t. Jpn J Antibiot. 1986 May;39(5):1241-9. Jpn J Antibiot. 1986. PMID: 3761554 Japanese.

10

Optimal sampling and limited sampling strategies for estimation of unbound platinum AUC after nedaplatin infusion.

Ishibashi T, Fukumura K, Yano Y, Oguma T. Ishibashi T, et al. Among authors: oguma t. Anticancer Res. 2005 Mar-Apr;25(2B):1283-9. Anticancer Res. 2005. PMID: 15865079 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters